Rtw Investments, LP Maxcyte, Inc. Transaction History

Rtw Investments, LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$3.59 - $6.81 $2.06 Million - $3.9 Million	573,168 Added 287.21%	772,735 $3.66 Million
Q1 2022 May 16, 2022	SELL	$5.26 - $10.84 $396,777 - $817,693	-75,433 Reduced 27.43%	199,567 $1.4 Million
Q3 2021 Nov 15, 2021	BUY	$12.21 - $17.2 $3.36 Million - $4.73 Million	275,000 New	275,000 $3.36 Million

124

65.6M

Ticker MXCT
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 101,724,000
Market Cap $451M
Description
MaxCyte, Inc., a global life sciences company, engages in the discovery, development, and commercialization of next-generation cell therapies. Its products include ExPERT ATx, a static electroporation instrument for small to medium scale transfection; ExPERT STx, a flow electroporation for protein production and drug development, as well as expr...

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Rtw Investments, LP with notifications on news.